Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Block

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Alimentary Pharmacology & Therapeutics|February 28, 2002
Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitusC E M De Block, I H De Leeuw, J J P M Bogers, et al.
Diabetes Care|May 27, 2004
Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetesChristophe E M De Block, Gert Colpin, Kristof Thielemans, et al.
Nature Medicine|October 10, 2022
Microbiome-derived ethanol in nonalcoholic fatty liver diseaseAbraham S Meijnikman, Mark Davids, Hilde Herrema, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Alimentary Pharmacology & Therapeutics|February 28, 2002
Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitusC E M De Block, I H De Leeuw, J J P M Bogers, et al.
Diabetes Care|May 27, 2004
Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetesChristophe E M De Block, Gert Colpin, Kristof Thielemans, et al.
Nature Medicine|October 10, 2022
Microbiome-derived ethanol in nonalcoholic fatty liver diseaseAbraham S Meijnikman, Mark Davids, Hilde Herrema, et al.
Pageof 4